Clinical Trials in Troy, New York
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
Follicular Lymphoma ( FL)
Genmab1,095 enrolled266 locationsNCT06191744
Recruiting
Not Applicable
The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
Venous UlcerVenous StenosisVenous Occlusion+7 more
W.L.Gore & Associates165 enrolled27 locationsNCT05489588